Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Beta Amyloid
    (1)
  • Proteasome
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

idps

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
TCH-165
T170111446350-60-2
TCH-165 is a small molecule modulator of proteasome assembly, resulting in an increase in 20S levels. The increase in the level of free 20S corresponds to enhanced proteolysis of IDPs.
  • $37
In Stock
Size
QTY
Dezamizumab
GSK2398852, GSK 2398852, Anti-Serum Amyloid P/SAP Reference Antibody (Dezamizumab)
T773911662664-56-3
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal immunoglobulin G1 (IgG1) antibody specifically targeting the serum amyloid P component (SAP), a protein universally found in all types of amyloid deposits, and it possesses potential anti-amyloid activity by triggering an immunotherapeutic mechanism for the clearance of amyloid fibrils through macrophage-mediated phagocytosis, which can be applied in the research of amyloid light-chain (AL) amyloidosis and other systemic amyloid diseases.
  • $328
In Stock
Size
QTY